β blockers in older persons with heart failure: Tolerability and impact on quality of life

Heart

Volumn 88, Issue 6, 2002, Pages 611-614

  Baxter, A John ^a   Spensley, A ^a   Hildreth, A ^a   Karimova, G ^a   O'Connell, J E ^a   Gray, C S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DIGOXIN; ENALAPRIL; FUROSEMIDE; LISINOPRIL; SPIRONOLACTONE;

AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TOLERABILITY; EXERCISE TOLERANCE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GERIATRIC CARE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH;

ADRENERGIC BETA-AGONISTS; AGED; AGED, 80 AND OVER; BISOPROLOL; BLOOD PRESSURE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TABLETS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036899667     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. CIBIS-II Investigators. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
2. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-7.
3. Sharpe N. Benefit of β-blockers for heart failure: Proven in 1999. Lancet 1999;353:2000.
4. Cowie MR, Wood DA, Coats AJS, et al. Incidence and aetiology of heart failure: A population based study. Eur Heart J 1999;6:421-8.
5. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25.
6. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993;22:6-13.
7. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left ventricular dysfunction in an urban population. Lancet 1997;350:829-33.
8. Schiller NB, Acquatella H, Ports TA, et al. Left ventricular volume from paired biplane two dimensional echocardiography. Circulation 1979;60:547-55.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
10. Guyatt GH, Nogradi S, Halcrow S, et al. Development and testing of a new measure of health status for clinical trials in heart failure. J Intern Med 1989;4:101-7.
11. O'Keefe ST, Lye M, Donnellan C, et al. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998;80:377-82.
12. Goldberg DP, Hillier VF. A scaled version of the general health questionnaire. Psychol Med 1979;9:139-45.
13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
14. Crabtree HL, Gray CS, Hildreth AJ, et al. The comorbidity symptom scale: A combined disease inventory and assessment of symptom severity. J Am Geriatr Soc 2000;48:1674-8.
15. Guyatt GH, Pugsley SO, Sulivan MJ, et al. The 6 minute walk test: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23.